Low-dose lipopolysaccharide and fungal airway exposure were linked to persistent airway hyperresponsiveness despite glucocorticoid treatment in experimental models.
Survey respondents favored maternal vaccination over infant antibody administration, and physician recommendations increased acceptance among some hesitant participants.
A real‐world Brazilian registry suggests that challenges in biologic distribution were associated with treatment interruption, particularly among therapies requiring more frequent dosing.